Skip to main content

Advertisement

SpringerLink
Log in

Dietary Fiber and Gastrointestinal Disease: an Evolving Story

  • Invited Commentary
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Burkitt DP, Walker AR, Painter NS. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet. 1972;2(7792):1408–12.

    Article  CAS  Google Scholar 

  2. Shanahan F. Fiber man meets microbial man. Am J Clin Nutr. 2015;101(1):1–2. https://doi.org/10.3945/ajcn.114.101550.

    Article  CAS  PubMed  Google Scholar 

  3. Coffin CS, Shaffer EA. The hot air and cold facts of dietary fibre. Can J Gastroenterol. 2006;20(4):255–6.

    Article  Google Scholar 

  4. McRorie JW Jr. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: what to look for and how to recommend an effective fiber therapy. Nutr Today. 2015;50(2):82–9. https://doi.org/10.1097/nt.0000000000000082.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Shanahan F, van Sinderen D, O’Toole PW, Stanton C. Feeding the microbiota: transducer of nutrient signals for the host. Gut. 2017;66(9):1709–17. https://doi.org/10.1136/gutjnl-2017-313872.

    Article  CAS  PubMed  Google Scholar 

  6. Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;19(3):245–51.

    Article  CAS  Google Scholar 

  7. El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary fiber in irritable bowel syndrome (review). Int J Mol Med. 2017;40(3):607–13. https://doi.org/10.3892/ijmm.2017.3072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Magge S, Lembo A. Low-FODMAP diet for treatment of irritable bowel syndrome. Gastroenterol Hepatol. 2012;8(11):739–45.

    Google Scholar 

  9. Quigley EMM. Editorial: balancing fibre and FODMAPs in IBS – a ‘rye’ look at an old problem. Aliment Pharmacol Ther. 2016;44(10):1134–5. https://doi.org/10.1111/apt.13805.

    Article  CAS  PubMed  Google Scholar 

  10. Stephen AM, Champ MM, Cloran SJ, Fleith M, van Lieshout L, Mejborn H, et al. Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health. Nutr Res Rev. 2017;30(2):149–90. https://doi.org/10.1017/s095442241700004x.

    Article  CAS  PubMed  Google Scholar 

  11. Qvitzau S, Matzen P, Madsen P. Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium. Scand J Gastroenterol. 1988;23(10):1237–40. https://doi.org/10.3109/00365528809090197.

    Article  CAS  PubMed  Google Scholar 

  12. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther. 1998;12(5):491–7.

    Article  CAS  Google Scholar 

  13. Cudmore S, Doolan A, Lacey S, Shanahan F. A randomised, double-blind, placebo-controlled clinical study: the effects of a synbiotic, Lepicol, in adults with chronic, functional constipation. Int J Food Sci Nutr. 2017;68(3):366–77. https://doi.org/10.1080/09637486.2016.1244661.

    Article  CAS  PubMed  Google Scholar 

  14. Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100(4):936–71. https://doi.org/10.1111/j.1572-0241.2005.40925.x.

    Article  PubMed  Google Scholar 

  15. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581–90. https://doi.org/10.1111/j.1572-0241.2006.00734.x.

    Article  PubMed  Google Scholar 

  16. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508–18. https://doi.org/10.1111/j.1365-2036.2008.03911.x.

    Article  CAS  PubMed  Google Scholar 

  17. Harris LA, Baffy N. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgrad Med. 2017;129(8):872–88. https://doi.org/10.1080/00325481.2017.1383819.

    Article  PubMed  Google Scholar 

  18. Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009;15(23):2887–92.

    Article  Google Scholar 

  19. Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn’s disease. Br Med J (Clin Res Ed). 1987;295(6597):517–20.

    Article  CAS  Google Scholar 

  20. Principi M, Losurdo G, Iannone A, Contaldo A, Deflorio V, Ranaldo N, et al. Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population. Ann Gastroenterol. 2018;31(4):469–73. https://doi.org/10.20524/aog.2018.0273.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20(3):576–86. https://doi.org/10.1097/01.mib.0000437984.92565.31.

    Article  PubMed  Google Scholar 

  22. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339–53.e21. https://doi.org/10.1016/j.cell.2016.10.043.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut. 2006;55(3):348–55. https://doi.org/10.1136/gut.2005.074971.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Hart AL, et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s disease. Gut. 2011;60(7):923–9. https://doi.org/10.1136/gut.2010.232025.

    Article  CAS  PubMed  Google Scholar 

  25. De Preter V, Joossens M, Ballet V, Shkedy Z, Rutgeerts P, Vermeire S, et al. Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn’s disease patients: a double-blinded randomized controlled trial. Clin Transl Gastroenterol. 2013;4(1):e30. https://doi.org/10.1038/ctg.2012.24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Joossens M, De Preter V, Ballet V, Verbeke K, Rutgeerts P, Vermeire S. Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial. Gut. 2012;61(6):958. https://doi.org/10.1136/gutjnl-2011-300413.

    Article  PubMed  Google Scholar 

  27. Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–45. https://doi.org/10.1016/j.cell.2016.05.041.

    Article  CAS  Google Scholar 

  28. Laserna-Mendieta EJ, Clooney AG, Carretero-Gomez JF, Moran C, Sheehan D, Nolan JA, et al. Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn’s disease and ulcerative colitis. J Crohn's Colitis. 2018;12(2):204–16. https://doi.org/10.1093/ecco-jcc/jjx137.

    Article  Google Scholar 

  29. Seminerio JL, Koutroubakis IE, Ramos-Rivers C, Hashash JG, Dudekula A, Regueiro M, et al. Impact of obesity on the management and clinical course of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(12):2857–63. https://doi.org/10.1097/mib.0000000000000560.

    Article  PubMed  Google Scholar 

  30. Flores A, Burstein E, Cipher DJ, Feagins LA. Obesity in inflammatory bowel disease: a marker of less severe disease. Dig Dis Sci. 2015;60(8):2436–45. https://doi.org/10.1007/s10620-015-3629-5.

    Article  CAS  PubMed  Google Scholar 

  31. Unlu C, Daniels L, Vrouenraets BC, Boermeester MA. A systematic review of high-fibre dietary therapy in diverticular disease. Int J Color Dis. 2012;27(4):419–27. https://doi.org/10.1007/s00384-011-1308-3.

    Article  Google Scholar 

  32. Lahner E, Esposito G, Zullo A, Hassan C, Cannaviello C, Paolo MCD, et al. High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol. 2012;18(41):5918–24. https://doi.org/10.3748/wjg.v18.i41.5918.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Crowe FL, Balkwill A, Cairns BJ, Appleby PN, Green J, Reeves GK, et al. Source of dietary fibre and diverticular disease incidence: a prospective study of UK women. Gut. 2014;63(9):1450–6. https://doi.org/10.1136/gutjnl-2013-304644.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005;294(22):2849–57. https://doi.org/10.1001/jama.294.22.2849.

    Article  CAS  PubMed  Google Scholar 

  35. Aune D, Chan DSM, Lau R, Vieira R, Greenwood DC, Kampman E, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011;343:d6617. https://doi.org/10.1136/bmj.d6617.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ma Y, Huang P, Hu M, Ling S, Li Y, Chen B, et al. Dietary fiber intake and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Clin Oncol. 2017;35(15_suppl):e15080-e. https://doi.org/10.1200/JCO.2017.35.15_suppl.e15080.

    Article  Google Scholar 

  37. Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, et al. Dietary fibre intake and risks of cancers of the colon and rectum in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS One. 2012;7(6):e39361. https://doi.org/10.1371/journal.pone.0039361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kunzmann AT, Coleman HG, Huang WY, Kitahara CM, Cantwell MM, Berndt SI. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2015;102(4):881–90. https://doi.org/10.3945/ajcn.115.113282.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Yao Y, Suo T, Andersson R, Cao Y, Wang C, Lu J, et al. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev. 2017;1:Cd003430. https://doi.org/10.1002/14651858.CD003430.pub2.

    Article  PubMed  Google Scholar 

  40. Chen J, Vitetta L. Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer. 2018;17(3):e541–e4. https://doi.org/10.1016/j.clcc.2018.05.001.

    Article  PubMed  Google Scholar 

  41. Eaton SB. The ancestral human diet: what was it and should it be a paradigm for contemporary nutrition? Proc Nutr Soc. 2006;65(1):1–6.

    Article  CAS  Google Scholar 

  42. Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23(6):705–15. https://doi.org/10.1016/j.chom.2018.05.012.

    Article  CAS  PubMed  Google Scholar 

  43. Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, et al. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model. Nat Microbiol. 2018;3(6):662–9. https://doi.org/10.1038/s41564-018-0150-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Schroeder BO, Birchenough GMH, Stahlman M, Arike L, Johansson MEV, Hansson GC, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe. 2018;23(1):27–40.e7. https://doi.org/10.1016/j.chom.2017.11.004.

    Article  CAS  PubMed  Google Scholar 

  45. Lampe JW, Navarro SL, Hullar MAJ, Shojaie A. Inter-individual differences in response to dietary intervention: integrating omics platforms toward personalised dietary recommendations. Proc Nutr Soc. 2013;72(2):207–18. https://doi.org/10.1017/S0029665113000025.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors are funded in part by Science Foundation Ireland (APC/SFI/12/RC/2273) in the form of a research center, APC Microbiome Ireland.

Author information

Authors and Affiliations

  1. Department of Medicine and APC Microbiome Ireland, University College Cork, National University of Ireland, Cork, Ireland

    John O’Grady & Fergus Shanahan

Authors
  1. John O’Grady
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fergus Shanahan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John O’Grady.

Ethics declarations

Conflict of Interest

John O'Grady is funded through APC Microbiome Ireland. Fergus Shanahan is a co-founder, shareholder in Atlantia Food Clinical Trials, 4D Pharma Cork Ltd., Alimentary Health Ltd. He is the director of the APC Microbiome Ireland, a research center funded in part by Science Foundation Ireland (APC/SFI/12/RC/2273).

Ashley Thomas, Silvio de Melo Jr., and Bruno Ribeiro declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Grady, J., Shanahan, F. Dietary Fiber and Gastrointestinal Disease: an Evolving Story. Curr Gastroenterol Rep 20, 59 (2018). https://doi.org/10.1007/s11894-018-0667-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11894-018-0667-0

Keywords

Search

Navigation